Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Enko"

20 News Found

Cellenkos scores FDA orphan drug designation for CK0804 in rare blood cancer
Drug Approval | January 08, 2026

Cellenkos scores FDA orphan drug designation for CK0804 in rare blood cancer

Receiving Orphan Drug Designation is an important milestone in the clinical development of CK0804 for myelofibrosis


Granules partners with Greenko ZeroC to enable green molecule solutions
Sustainability | January 03, 2023

Granules partners with Greenko ZeroC to enable green molecule solutions

Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.


Surendran Chemmenkotil to join as CEO of Metropolis Healthcare
People | December 12, 2022

Surendran Chemmenkotil to join as CEO of Metropolis Healthcare

He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel


Enko advances Enkompass platform through DNA-encoded library technology
News | June 16, 2022

Enko advances Enkompass platform through DNA-encoded library technology

Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions


Global Cord Blood Corp acquires Cellenkos to advance cell therapy market
Biotech | May 01, 2022

Global Cord Blood Corp acquires Cellenkos to advance cell therapy market

CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products


BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price
Supply Chain | April 27, 2026

BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price

The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform


Metropolis Healthcare launches blood-based test for early Alzheimer’s detection
Healthcare | April 27, 2026

Metropolis Healthcare launches blood-based test for early Alzheimer’s detection

New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines


Bristol Myers Squibb launches AI-powered ‘Mosaic’ hub in Mumbai
News | December 17, 2025

Bristol Myers Squibb launches AI-powered ‘Mosaic’ hub in Mumbai

India plays a critical role in Bristol Myers Squibb’s global strategy


BMS’ Cobenfy sees steady start, eyes stronger growth ahead
News | October 31, 2025

BMS’ Cobenfy sees steady start, eyes stronger growth ahead

Cobenfy generated $43 million in third-quarter sales, up from $35 million in the second quarter